Related Experiment Video
Updated: May 22, 2025

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
Correlation between dietary vitamin B2 intake and helicobacter pylori infection in US adults: a cross-sectional study
Yingxiu Huang1, Ting Ao1, Peng Zhen1
1Department of Infectious Disease, Beijing Luhe Hospital, Capital Medical University, Beijing, 101149, China.
Objectives:
Helicobacter pylori (H. pylori) infection is a widely recognized factor in causing inflammation in the stomach and significantly increases the likelihood of developing gastric cancer. The relation between intake of vitamin B2 in the diet and testing positive for Helicobacter pylori is still unclear.
Methods:
This cross-sectional study used data from the NHANES conducted in the United States in 1999-2000. Vitamin B2 consumption was measured from one 24-hour recall interview. H. pylori seropositivity was confirmed through an ELISA test measuring serum lgG protein levels. Multivariable logistic regression models, subgroup analysis and sensitivity analysis were performed to evaluate the possible association between dietary vitamin B2 consumption and H. pylori seropositivity.
Results:
Out of the total 2,859 participants, 1,257 had H. pylori seropositivity, with males making up 47.5% and the mean age was 49.7 years old. There was a significant inverse association between vitamin B2 intake and H. pylori [odds ratio (OR): 0.88, 95% confidence interval (CI) (0.78-0.99), p = 0.031], after full adjustment for covariates. When dietary vitamin B2 analyzed as a categorical variable, the risk of H. pylori seropositivity in the highest quartile Q4 group decreased by 39% compared to lowest quartile Q1 (OR 0.61, 95% CI 0.44-0.86, p = 0.004, Model 3). The findings of subgroup analysis and sensitivity analysis were constant and dependable.
Conclusion:
This study implies that increased dietary vitamin B2 consumption may be related with a decreased incidence of Helicobacter pylori seropositivity.
More Related Videos
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Cancer Prevention
Some...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors